Search Information and Guidance

For product or manufacturer information - use our online information database IRIS

For Resources on thDischarge Medicines Service - Access here

For Employment and Health & Safety Advise - access valuable guidance and support provided by Ellis Whittam


Community pharmacy has managed to come this far in keeping the nation safe through the pandemic through helping each other and working together. It’s for this reason the cover feature shines a spotlight on teamwork and pharmacy’s role within the wider NHS family. The magazine also features an interview with Helen Walker, Chief Executive of Carers UK. Helen explains the difficulties carers have…


In the autumn edition we hone in on one rapidly emerging aspect of health care delivery – teleconsultations. In response to the virus, GPs quickly adopted remote ways of working, but what about community pharmacies, which pride themselves on the local, accessible, face to face care they provide? Other topics featured in this packed and varied issue include obesity, flu, the Falsified Medicines…


This special COVID-19 issue of InPharmacy provides a definitive guide to coronavirus for community pharmacy teams.


The spring edition of InPharmacy features the latest medication safety officer report, changes to the IR35 rule, CPCS and frequently asked questions and a feature on how pharmacists can broach tricky questions and sensitive subjects.


The winter edition of InPharmacy features the latest medication safety officer report, an update on the contractual framework in England, providing consultations and a look at workforce across the UK.


The autumn edition of InPharmacy features the topic of over-prescribing and the magazine also includes opinion and practical advice about the new pharmacy contractual framework in England.


In this special Finance issue: learn how to manage costs, generate new income and improve cash flow. NPA members share top tips for financial success and security.


This issue: Looks at major developments coming into effect in early 2019, including the Falsified Medicines Directive (FMD) on 9 February, and Brexit (probably) on 29 March. Both have significant implications for pharmacy business and practice. This edition of inPharmacy covers all these matters, and much else of interest besides. 


This issue: Looks at Opiod addiction, plus a government review into Opiod prescriptions to assess the scale of the issue.


This issue: See you sooner - how an increased role for pharmacists could ease strain on the NHS and improve access.